This year, buyers who bought shares of multibagger Remedium Lifecare Ltd. made 2700% on their money. On December 30, 2020, the stock finished at Rs 141.70. On June 23, 2023, it was worth Rs 3,939.70, which is a 2700% gain. The Sensex, on the other hand, is up 3.52% this year. Last time, Remedium Lifecare stock finished the day at Rs 3939.70, which was 4.73% higher than the start of the day. On BSE, the stock started at Rs 3924.95, which was better than the previous close of Rs 3761.60.
In the last seven days, the multibagger stock has gained 38.21%. The stock reached a new high of Rs 3,949.65 the day before.
The company’s market value went up to Rs 1418.29 crore. On the BSE, a total of 0.10 million shares were traded, which brought in Rs 3.94 crore. On September 23, 2022, Remedium Lifecare stock hit a 52-week low of Rs 136.15.
In terms of technicals, Remedium Lifecare stock’s relative strength index (RSI) is at 87.8, which means it is very overvalued. The one-year beta for Remedium Lifecare stock is -0.2, which means that the stock was very stable during that time. The 5-day, 10-day, 20-day, 50-day, 100-day, and 200-day moving averages are all higher than the price of Remedium Lifecare shares.
In the March quarter of the last fiscal year, Remedium Lifecare lost Rs 4.78 crore. In the March quarter of 2022, the company lost Rs 1.16 crore. But sales went up from Rs 40.29 crore in the quarter that ended in March 2022 to Rs 75.58 crore in Q4.
For the fiscal year that finished in March 2023, the company made Rs 5 crore, which was more than the Rs 1 crore it made the year before. In the last fiscal year, sales went up from Rs 505 crore to Rs 510 crore. The last fiscal year ended in March 2022.
For the quarter that finished in March 2023, one manager owned 1.11 percent of the company, or 40,000 shares, and 704 public shareholders owned 98.89 percent, or 35.60 lakh shares. Of these, 630 people who lived in India owned 4.01 million shares, or an 11.16 percent stake, with up to Rs 2 lakh in cash. For the quarter that finished in March 2023, only 37 owners with a 75.07% stake, or 27.02 lakh shares, had capital above Rs 2 lakh.
As a pharmacy company, Remedium Lifecare is focused on two business areas: goods and services. Products business includes buying and selling APIs and intermediates to creator and copycat pharmaceutical companies on both local and foreign markets, including controlled markets.
